Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
63
PBI Quote, Financials, Valuation and Earnings
Last price:
$10.51
Seasonality move
:
5.56%
Day range:
$10.48 - $10.66
52-week range:
$6.88 - $13.11
Dividend yield:
2.84%
P/E ratio:
24.58x
P/S ratio:
0.98x
P/B ratio:
--
Volume:
3.4M
Avg. volume:
2.7M
1-year change:
45.99%
Market cap:
$1.7B
Revenue:
$2B
EPS (TTM):
$0.43
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.7B | $3.5B | $2.1B | $2B | |
| Revenue Growth (YoY) | 10.89% | 3.35% | -3.68% | -41.24% | -2.52% | |
| Cost of Revenues | $2.4B | $2.6B | $2.5B | $1B | $964.3M | |
| Gross Profit | $1.1B | $1.1B | $1.1B | $1B | $1.1B | |
| Gross Profit Margin | 32.34% | 30.54% | 30.53% | 49.57% | 52.42% | |
| R&D Expenses | $38.4M | $46.8M | $43.7M | $29.5M | $32M | |
| Selling, General & Admin | $963.3M | $924.2M | $905.6M | $897.3M | $717.9M | |
| Other Inc / (Exp) | -$225.3M | -$61.6M | -$4.4M | -$164.7M | -$254.7M | |
| Operating Expenses | $1B | $966.4M | $921M | $807.1M | $749.9M | |
| Operating Income | $142.3M | $155.4M | $159.3M | $223.5M | $312.4M | |
| Net Interest Expenses | $105.8M | $96.5M | $90.5M | $108.5M | $120.2M | |
| EBT. Incl. Unusual Items | -$183.4M | -$7.4M | $39.9M | -$43.9M | -$52.3M | |
| Earnings of Discontinued Ops. | $10.1M | -$4.9M | -- | -$324.4M | -$306.1M | |
| Income Tax Expense | $7.1M | -$10.9M | $2.9M | $17.3M | -$154.8M | |
| Net Income to Company | -$180.4M | -$1.4M | $36.9M | -$61.3M | $102.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$190.5M | $3.5M | $36.9M | -$61.3M | $102.5M | |
| Basic EPS (Cont. Ops) | -$1.11 | $0.02 | $0.21 | -$2.20 | $0.06 | |
| Diluted EPS (Cont. Ops) | -$1.11 | $0.02 | $0.21 | -$2.20 | $0.06 | |
| Weighted Average Basic Share | $171.5M | $173.9M | $173.9M | $175.6M | $179.5M | |
| Weighted Average Diluted Share | $171.5M | $179.1M | $177.3M | $175.6M | $182.5M | |
| EBITDA | $302.9M | $318.3M | $323.1M | $336.2M | $426.9M | |
| EBIT | $142.3M | $155.4M | $159.3M | $223.5M | $312.4M | |
| Revenue (Reported) | $3.6B | $3.7B | $3.5B | $2.1B | $2B | |
| Operating Income (Reported) | $142.3M | $155.4M | $159.3M | $223.5M | $312.4M | |
| Operating Income (Adjusted) | $142.3M | $155.4M | $159.3M | $223.5M | $312.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $875.4M | $830.9M | $503M | $499.5M | $459.7M | |
| Revenue Growth (YoY) | -1.86% | -5.08% | -39.46% | -0.71% | -7.97% | |
| Cost of Revenues | $601.6M | $580.5M | $248M | $238M | $215.4M | |
| Gross Profit | $273.8M | $250.4M | $255M | $261.5M | $244.3M | |
| Gross Profit Margin | 31.28% | 30.14% | 50.69% | 52.35% | 53.14% | |
| R&D Expenses | $10.6M | $9.8M | $7.7M | $7.6M | $3.4M | |
| Selling, General & Admin | $225M | $209.6M | $182.7M | $190M | $144.2M | |
| Other Inc / (Exp) | -$6.9M | $4.1M | -$11.3M | -$80M | -- | |
| Operating Expenses | $229.9M | $243.6M | $178.5M | $197.6M | $147.6M | |
| Operating Income | $44M | $6.8M | $76.5M | $63.9M | $96.7M | |
| Net Interest Expenses | $24.2M | $23.8M | $26.5M | $30.4M | $26.1M | |
| EBT. Incl. Unusual Items | $7M | $10.1M | $26.9M | -$43.9M | $68.1M | |
| Earnings of Discontinued Ops. | $572K | -- | -$30.3M | -$261.1M | -- | |
| Income Tax Expense | -$1.5M | $4.6M | $9.1M | -$166.5M | $16.2M | |
| Net Income to Company | $9.1M | $5.5M | $149.6M | $172.3M | $52M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.5M | $5.5M | $17.8M | $122.6M | $52M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.03 | -$0.07 | $0.45 | $0.31 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.03 | -$0.07 | $0.44 | $0.31 | |
| Weighted Average Basic Share | $174.4M | $173.8M | $176.1M | $180.2M | $168.9M | |
| Weighted Average Diluted Share | $179.4M | $177M | $176.1M | $183.8M | $170.4M | |
| EBITDA | $85.8M | $46.1M | $81.3M | $68.2M | $124.1M | |
| EBIT | $44M | $6.8M | $76.5M | $63.9M | $96.7M | |
| Revenue (Reported) | $875.4M | $830.9M | $503M | $499.5M | $459.7M | |
| Operating Income (Reported) | $44M | $6.8M | $76.5M | $63.9M | $96.7M | |
| Operating Income (Adjusted) | $44M | $6.8M | $76.5M | $63.9M | $96.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.6B | $3B | $2B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6B | $2.5B | $2B | $984.4M | $892.6M | |
| Gross Profit | $1.2B | $1.1B | $1B | $1.1B | $1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $42.5M | $46.2M | $39.7M | $30.6M | $21.3M | |
| Selling, General & Admin | $941.8M | $903.8M | $874M | $849.4M | $628.9M | |
| Other Inc / (Exp) | -$57.8M | -$2.7M | -$164.9M | -$210.1M | -- | |
| Operating Expenses | $979.8M | $995.3M | $820.6M | $798.6M | $650.1M | |
| Operating Income | $170.7M | $82.7M | $215.5M | $253.9M | $388.4M | |
| Net Interest Expenses | $99.8M | $90M | $95.3M | $128.4M | $104.3M | |
| EBT. Incl. Unusual Items | $8.6M | $33.9M | -$127.6M | -$66.7M | $106M | |
| Earnings of Discontinued Ops. | -$1.9M | -$524K | -$30.3M | -$473.1M | $4.7M | |
| Income Tax Expense | -$11M | $1.5M | -$2.4M | -$149.7M | $30.7M | |
| Net Income to Company | $17.4M | $31.9M | $6.6M | $132.7M | $75.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $19.5M | $32.4M | -$125.2M | $83M | $75.3M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.19 | -$0.88 | -$0.98 | $0.44 | |
| Diluted EPS (Cont. Ops) | $0.10 | $0.18 | -$0.89 | -$0.99 | $0.43 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $332.1M | $249M | $339M | $343.7M | $501.5M | |
| EBIT | $170.7M | $82.7M | $215.5M | $253.9M | $388.4M | |
| Revenue (Reported) | $3.7B | $3.6B | $3B | $2B | $1.9B | |
| Operating Income (Reported) | $170.7M | $82.7M | $215.5M | $253.9M | $388.4M | |
| Operating Income (Adjusted) | $170.7M | $82.7M | $215.5M | $253.9M | $388.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.6B | $2.1B | $1.5B | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $1.8B | $1.4B | $725.8M | $654.1M | |
| Gross Profit | $850.1M | $806.3M | $761.9M | $784.7M | $760.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $33M | $32.4M | $28.5M | $22.5M | $11.8M | |
| Selling, General & Admin | $699.3M | $679M | $647.4M | $626.2M | $480.6M | |
| Other Inc / (Exp) | -$53.1M | $5.8M | -$152.8M | -$114.2M | -$32.8M | |
| Operating Expenses | $727.8M | $756.8M | $656.4M | $592.1M | $492.4M | |
| Operating Income | $122.2M | $49.5M | $105.5M | $192.6M | $268.5M | |
| Net Interest Expenses | $73.6M | $67.1M | $72M | $91.2M | $75.3M | |
| EBT. Incl. Unusual Items | -$8.9M | $32.5M | -$135M | -$4.1M | $154.1M | |
| Earnings of Discontinued Ops. | -$4.3M | -- | -$30.3M | -$310.8M | -- | |
| Income Tax Expense | -$10.6M | $1.8M | -$3.6M | -$148.7M | $36.8M | |
| Net Income to Company | -$2.6M | $30.6M | $301K | $194.3M | $117.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.7M | $30.6M | -$131.5M | $144.6M | $117.4M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.18 | -$0.92 | $0.29 | $0.67 | |
| Diluted EPS (Cont. Ops) | $0.00 | $0.17 | -$0.92 | $0.28 | $0.66 | |
| Weighted Average Basic Share | $521.2M | $521.5M | $526.4M | $535.9M | $531.5M | |
| Weighted Average Diluted Share | $531.2M | $532M | $526.4M | $544M | $536.1M | |
| EBITDA | $243.5M | $174.3M | $190M | $254.2M | $353M | |
| EBIT | $122.2M | $49.5M | $105.5M | $192.6M | $268.5M | |
| Revenue (Reported) | $2.7B | $2.6B | $2.1B | $1.5B | $1.4B | |
| Operating Income (Reported) | $122.2M | $49.5M | $105.5M | $192.6M | $268.5M | |
| Operating Income (Adjusted) | $122.2M | $49.5M | $105.5M | $192.6M | $268.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $940.4M | $746.9M | $681.2M | $622.2M | $486.1M | |
| Short Term Investments | $19M | $14.4M | $11.2M | $22.2M | $16.4M | |
| Accounts Receivable, Net | $957.3M | $895.3M | $908.5M | $763.8M | $695.6M | |
| Inventory | $71.5M | $78.6M | $83.7M | $63M | $59.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $120.1M | $157.3M | $115.8M | $76M | $66M | |
| Total Current Assets | $2.1B | $1.9B | $1.8B | $2.1B | $1.3B | |
| Property Plant And Equipment | $631.6M | $672.4M | $744.3M | $404.2M | $356.6M | |
| Long-Term Investments | $969.5M | $923.6M | $902.4M | $903.3M | $800.8M | |
| Goodwill | $1.2B | $1.1B | $1.1B | $734.4M | $721M | |
| Other Intangibles | $159.8M | $132.4M | $77.9M | $20.4M | $15.8M | |
| Other Long-Term Assets | $127.3M | $138M | $120.4M | $90.8M | $85.7M | |
| Total Assets | $5.2B | $5B | $4.7B | $4.3B | $3.4B | |
| Accounts Payable | $295.2M | $311M | $315.4M | $273.6M | $239.7M | |
| Accrued Expenses | $187.4M | $192.1M | $165.8M | -- | $143.1M | |
| Current Portion Of Long-Term Debt | $216M | $24.7M | $32.8M | $58.9M | $53.3M | |
| Current Portion Of Capital Lease Obligations | $39.2M | $40.3M | $52.6M | $29.9M | $26.9M | |
| Other Current Liabilities | -- | -- | -- | $257.1M | -- | |
| Total Current Liabilities | $1.9B | $1.7B | $1.7B | $1.9B | $1.7B | |
| Long-Term Debt | $2.5B | $2.5B | $2.5B | $2.2B | $2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.2B | $4.8B | $4.7B | $4.6B | $4B | |
| Common Stock | $323.3M | $323.3M | $323.3M | $270.3M | $270.3M | |
| Other Common Equity Adj | -$839.1M | -$780.3M | -$835.6M | -$851.2M | -$839.2M | |
| Common Equity | $70.6M | $112.6M | $60.7M | -$368.6M | -$578.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $70.6M | $112.6M | $60.7M | -$368.6M | -$578.4M | |
| Total Liabilities and Equity | $5.2B | $5B | $4.7B | $4.3B | $3.4B | |
| Cash and Short Terms | $940.4M | $746.9M | $681.2M | $622.2M | $486.1M | |
| Total Debt | $2.8B | $2.6B | $2.5B | $2.3B | $2.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $743.2M | $606.7M | $579.4M | $575.5M | $336M | |
| Short Term Investments | $14.1M | $10M | $21.7M | $14M | -- | |
| Accounts Receivable, Net | $870.8M | $839.2M | $838.7M | $719.5M | $659.3M | |
| Inventory | $69.5M | $89.9M | $83.8M | $71.6M | $75.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $127.5M | $146.6M | $109.2M | $99.8M | -- | |
| Total Current Assets | $1.8B | $1.7B | $1.6B | $1.5B | $1.1B | |
| Property Plant And Equipment | $715.9M | $715.7M | $726.3M | $374M | $314.1M | |
| Long-Term Investments | $583M | $613.2M | $652.9M | $624.5M | $624.5M | |
| Goodwill | $1.1B | $1B | $945.4M | $737.3M | -- | |
| Other Intangibles | $137.1M | $79.4M | $66.1M | $17M | -- | |
| Other Long-Term Assets | $484.2M | $388.7M | $370.7M | $320M | -- | |
| Total Assets | $5B | $4.6B | $4.4B | $3.6B | $3.3B | |
| Accounts Payable | $868.9M | $763.4M | $792.9M | $852.6M | $698.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $24.7M | $27.1M | $56.5M | $56.5M | -- | |
| Current Portion Of Capital Lease Obligations | $41.3M | $45.8M | $58.3M | $29.2M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.6B | $1.6B | $1.7B | $1.4B | |
| Long-Term Debt | $2.5B | $2.4B | $2.4B | $2.2B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.9B | $4.6B | $4.5B | $4.2B | $3.9B | |
| Common Stock | $323.3M | $323.3M | $323.3M | $270.3M | $270.3M | |
| Other Common Equity Adj | -$841.2M | -$905.5M | -$838.1M | -$820.9M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $48.7M | -$8.3M | -$125.1M | -$518.9M | -$661.5M | |
| Total Liabilities and Equity | $5B | $4.6B | $4.4B | $3.6B | $3.3B | |
| Cash and Short Terms | $743.2M | $606.7M | $579.4M | $575.5M | $336M | |
| Total Debt | $2.5B | $2.5B | $2.4B | $2.2B | $2.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$180.4M | -$1.4M | $36.9M | -$61.3M | $102.5M | |
| Depreciation & Amoritzation | $160.6M | $162.9M | $163.8M | $112.7M | $114.5M | |
| Stock-Based Compensation | $17.5M | $20.9M | $16.6M | $8.9M | $16.5M | |
| Change in Accounts Receivable | $23.3M | $58.4M | -$41.9M | $22.8M | $92.3M | |
| Change in Inventories | $1.6M | -$8M | -$4.9M | $18.2M | $2.3M | |
| Cash From Operations | $302M | $301.5M | $176M | $69.6M | $215.5M | |
| Capital Expenditures | $105M | $184M | $124.8M | $78.1M | $72.4M | |
| Cash Acquisitions | $6.6M | $15M | $5.1M | -- | -- | |
| Cash From Investing | -$75.7M | -$155.3M | -$24.3M | -$124.1M | -$49.1M | |
| Dividends Paid (Ex Special Dividend) | $34.3M | $34.8M | $34.7M | $35.2M | $36M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $916.5M | $1.2B | -- | $266.8M | -- | |
| Long-Term Debt Repaid | -$1.1B | -$1.4B | -$124.1M | -$322.9M | -$233.9M | |
| Repurchase of Common Stock | -- | -- | $13.4M | -- | -- | |
| Other Financing Activities | -$12M | -$45.3M | -$16.2M | $69.4M | -$28.7M | |
| Cash From Financing | -$235.4M | -$330.4M | -$198.1M | -$19.5M | -$291.8M | |
| Beginning Cash (CF) | $921.5M | $732.5M | $670M | $600.1M | $469.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3M | -$189M | -$62.5M | -$68.3M | -$130.3M | |
| Ending Cash (CF) | $924.6M | $538.6M | $591.4M | $537.5M | $334.4M | |
| Levered Free Cash Flow | $197M | $117.5M | $51.1M | -$8.5M | $143.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.1M | $5.5M | $149.6M | $172.3M | $52M | |
| Depreciation & Amoritzation | $41.8M | $39.3M | $4.7M | $4.3M | $27.4M | |
| Stock-Based Compensation | $3.2M | $5.4M | $650K | $3.8M | $2.8M | |
| Change in Accounts Receivable | -$9M | -$27.8M | -$35.1M | -$47.1M | $14.2M | |
| Change in Inventories | -$2.4M | -$8.2M | $12.9M | -$1.5M | $2.9M | |
| Cash From Operations | $71.4M | -$36.5M | $19.8M | $9.4M | $58.3M | |
| Capital Expenditures | $57.2M | $33.4M | -$4.4M | $9.1M | $15.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$43.7M | $43.9M | -$34.7M | -$38.6M | -$36.4M | |
| Dividends Paid (Ex Special Dividend) | $8.7M | $8.7M | $8.8M | $9.1M | $13.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $266.8M | -- | -- | |
| Long-Term Debt Repaid | -$90M | -$6.2M | -$250.5M | -$14.1M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $161.5M | |
| Other Financing Activities | $5.9M | $45.2M | $28.7M | $17.5M | -- | |
| Cash From Financing | -$92.8M | $30.3M | $36.6M | -$2.3M | $14.6M | |
| Beginning Cash (CF) | $729.1M | $596.6M | $557.7M | $561.5M | $321M | |
| Foreign Exchange Rate Adjustment | -$5.3M | -$11.8M | -$5M | $3.9M | -$705K | |
| Additions / Reductions | -$70.3M | $26M | $16.6M | -$27.6M | $35.8M | |
| Ending Cash (CF) | $653.5M | $610.8M | $569.2M | $537.8M | $356.1M | |
| Levered Free Cash Flow | $14.2M | -$69.8M | $24.2M | $296K | $42.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $17.4M | $31.9M | $6.6M | $132.7M | $75.3M | |
| Depreciation & Amoritzation | $161.4M | $166.4M | $123.6M | $89.8M | $113.1M | |
| Stock-Based Compensation | $17.7M | $20.7M | $8.1M | $12M | $21.2M | |
| Change in Accounts Receivable | $40.2M | -$12.2M | -$29.4M | $8.9M | $118.3M | |
| Change in Inventories | -$3.8M | -$15.9M | $11.1M | $7.1M | -$4M | |
| Cash From Operations | $327.5M | $89.8M | $147.1M | $183.4M | $258.2M | |
| Capital Expenditures | $165.1M | $140.7M | $77.5M | $67.8M | $68.2M | |
| Cash Acquisitions | -- | $15M | $5.1M | -- | -- | |
| Cash From Investing | -$91.6M | -$27.2M | -$136.1M | -$95M | -$93.2M | |
| Dividends Paid (Ex Special Dividend) | $34.6M | $34.8M | $35M | $35.7M | $46M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.5B | -$129.1M | -$319.9M | -$56.5M | -- | |
| Repurchase of Common Stock | -- | $13.4M | -- | -- | $251.8M | |
| Other Financing Activities | -$27.2M | $2.6M | $39.5M | $5.5M | -- | |
| Cash From Financing | -$309.8M | -$169.9M | -$58.2M | -$91M | -$401.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$70M | -$132.5M | -$38.4M | $4.6M | -$240.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $162.4M | -$50.9M | $69.5M | $115.6M | $190M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.6M | $30.6M | $301K | $194.3M | $117.4M | |
| Depreciation & Amoritzation | $121.2M | $124.8M | $84.5M | $61.6M | $84.5M | |
| Stock-Based Compensation | $15.4M | $15.2M | $6.7M | $9.8M | $15M | |
| Change in Accounts Receivable | $94.4M | $23.8M | $36.2M | $22.4M | $90.2M | |
| Change in Inventories | -$4.3M | -$12.2M | $3.8M | -$7.2M | -$14.8M | |
| Cash From Operations | $216.2M | $4.5M | -$24.4M | $89.4M | $132.4M | |
| Capital Expenditures | $140.9M | $97.5M | $50.2M | $39.9M | $46M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$111.7M | $16.4M | -$95.4M | -$66.3M | -$110.5M | |
| Dividends Paid (Ex Special Dividend) | $26.1M | $26M | $26.3M | $26.8M | $36.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | -- | $266.8M | -- | $775M | |
| Long-Term Debt Repaid | -$1.4B | -$113M | -$308.8M | -$42.4M | -$804.4M | |
| Repurchase of Common Stock | -- | $13.4M | -- | -- | $251.8M | |
| Other Financing Activities | -$31.7M | $16.2M | $71.9M | $8.1M | -$65.2M | |
| Cash From Financing | -$291.8M | -$131.4M | $8.5M | -$63.1M | -$173.3M | |
| Beginning Cash (CF) | $2.2B | $1.8B | $1.6B | $1.7B | $930M | |
| Foreign Exchange Rate Adjustment | -$4.9M | -$25.3M | -$311K | $1.2M | $2.6M | |
| Additions / Reductions | -$192.3M | -$135.8M | -$111.7M | -$38.9M | -$148.7M | |
| Ending Cash (CF) | $2B | $1.6B | $1.5B | $1.6B | $783.9M | |
| Levered Free Cash Flow | $75.3M | -$93.1M | -$74.7M | $49.5M | $86.4M | |
Get PBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PBI
Sector
P/E ratio
24.58x
19.19x
PEG ratio
-0.03x
0.18x
P/B ratio
--
1.69x
Price / LTM sales
0.98x
0.85x
Growth Metrics
PBI
Sector
Revenue growth
-7.97%
5.01%
Earnings growth
-30.24%
5.65%
Revenue (5-year growth)
-8.76%
4.27%
Earnings forecast
$0.38
$0.35
Profitability
PBI
Sector
Profitability FY 2024
$1.1B
$252.3M
Return on invested capital
4.83%
4.72%
Return on assets
2.24%
3.09%
Return on equity
--
8.11%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
10
Estimated Next Earnings Date
Jan
28
Balance Sheet
PBI
Sector
Total cash
$336M
$138.8M
Short term investments
$16.4M
$32.3M
Total assets
$3.4B
$1.4B
Long term debt
$2.2B
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.14% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
